These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29951563)

  • 1. Infliximab-Induced Aseptic Meningitis in a Patient with Crohn's Disease.
    Junga Z; Theeler B; Singla M
    ACG Case Rep J; 2018; 5():e48. PubMed ID: 29951563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab-induced headache and infliximab-induced meningitis: two ends of the same spectrum?
    Hegde N; Gayomali C; Rich MW
    South Med J; 2005 May; 98(5):564-6. PubMed ID: 15954516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
    Keating GM; Perry CM
    BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study.
    Schröder O; Blumenstein I; Stein J
    Eur J Gastroenterol Hepatol; 2006 Jan; 18(1):11-6. PubMed ID: 16357613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
    Absah I; Faubion WA
    Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab-Induced Aseptic Meningitis during the Treatment of Psoriatic Arthritis.
    Matsuura-Otsuki Y; Hanafusa T; Yokozeki H; Watanabe K
    Case Rep Dermatol; 2017; 9(2):26-29. PubMed ID: 28611632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab: a review of its use in Crohn's disease and rheumatoid arthritis.
    Onrust SV; Lamb HM
    BioDrugs; 1998 Nov; 10(5):397-422. PubMed ID: 18020611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Tamponade as a Presenting Manifestation of Infliximab-Induced Lupus in Patient Treated for Crohn's Disease.
    Naseer M; Kulairi Z; Kam M
    ACG Case Rep J; 2017; 4():e1. PubMed ID: 28138445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Listeria meningitis complicating infliximab treatment for Crohn's disease.
    Williams G; Khan AA; Schweiger F
    Can J Infect Dis Med Microbiol; 2005 Sep; 16(5):289-92. PubMed ID: 18159561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab in treatment of Crohn's disease: the Milan experience.
    Ardizzone S; Colombo E; Maconi G; Bollani S; Manzionna G; Petrone MC; Bianchi Porro G
    Dig Liver Dis; 2002 Jun; 34(6):411-8. PubMed ID: 12132788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of refractory pediatric Crohn's disease with a successful treatment by infliximab therapy].
    Park SH; Jeen YT; Chun HR; Kim DI; Baeck CW; Kim YS; Chun HJ; Lee HS; Um SH; Choi JH; Kim CD; Ryu HS; Hyun JH
    Korean J Gastroenterol; 2005 Oct; 46(4):297-301. PubMed ID: 16247274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical Arthralgia Secondary to Anti-Tumor-Necrosis-Factor Alpha Therapy in Crohn's Disease.
    Thurlapati A; Gandu SSK; Kulkarni S
    Cureus; 2021 Jun; 13(6):e15835. PubMed ID: 34327073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW; Bickston SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining infliximab and methotrexate in fistulizing Crohn's disease resistant or intolerant to azathioprine.
    Schröder O; Blumenstein I; Schulte-Bockholt A; Stein J
    Aliment Pharmacol Ther; 2004 Feb; 19(3):295-301. PubMed ID: 14984376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease.
    Di Sabatino A; Ciccocioppo R; Cinque B; Millimaggi D; Morera R; Ricevuti L; Cifone MG; Corazza GR
    Gut; 2004 Jan; 53(1):70-7. PubMed ID: 14684579
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.